Duluth (DLTH) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
19 Mar, 2026Executive summary
Achieved third consecutive quarter of improved gross margin, lower costs, reduced inventory, and enhanced profitability.
Adjusted EBITDA for the year rose by $10.3 million to $24.9 million, with positive free cash flow of $16.6 million, a $41.8 million improvement year-over-year.
Full-year net loss narrowed to $16.2 million from $43.6 million in the previous year.
Fourth quarter net income reached $7.8 million, reversing a $5.6 million loss from the prior year.
Inventory reduced by $35 million (21%) versus last year, supporting improved liquidity and operational efficiency.
Financial highlights
Q4 net sales were $215.9 million, down 10.5% year-over-year (8.3% excluding prior year's 53rd week).
Full-year net sales were $565.2 million, down 9.8%; gross margin expanded by 420 basis points to 53.4%.
Q4 gross margin expanded by 890 basis points to 53%.
Adjusted EBITDA for the year was $24.9 million, up $10.3 million; adjusted EBITDA margin rose to 4.4% from 2.3%.
Ended year with $141.3 million in net liquidity and no debt on the ABL facility.
Outlook and guidance
FY2026 net sales projected at $540–$560 million, down 1%–5% year-over-year.
Adjusted EBITDA guidance of $26–$30 million for FY2026.
Capital expenditures planned at $12 million, focused on growth, infrastructure, and maintenance.
First half of 2026 expected to see sales decline of 6%–10%, stabilizing to -2% to +2% in the second half.
Gross margin expected to expand by 100 basis points to 54.4%.
Latest events from Duluth
- Q2 net sales up 1.8%, gross margin expanded, and FY2024 outlook reaffirmed.DLTH
Q2 202522 Jan 2026 - Q3 net sales fell 8.1% to $127.1M, gross margin rose to 52.3%, net loss reached $28.5M.DLTH
Q3 202511 Jan 2026 - Sales fell 3% to $626.6M; 2025 outlook targets EBITDA growth and no debt.DLTH
Q4 202526 Dec 2025 - Profitability and margins improved with higher gross margin and lower costs, despite lower sales.DLTH
Q3 202619 Dec 2025 - Board elections, CEO transition, and auditor ratification headline the annual meeting agenda.DLTH
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting, no fee required.DLTH
Proxy Filing1 Dec 2025 - Q1 net sales fell 12% with a wider loss, but cost cuts and new credit support 2025 guidance.DLTH
Q1 202613 Nov 2025 - Net income turned positive and gross margin expanded, with guidance and liquidity stable.DLTH
Q2 20265 Sep 2025